Blend Labs, Inc. (NYSE:BLND - Get Free Report) Director Timothy J. Mayopoulos sold 42,721 shares of the company's stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $5.00, for a total transaction of $213,605.00. Following the completion of the transaction, the director now directly owns 387,620 shares in the company, valued at $1,938,100. The trade was a 9.93 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Blend Labs Price Performance
Shares of BLND traded down $0.01 during mid-day trading on Friday, reaching $5.20. The company's stock had a trading volume of 3,238,744 shares, compared to its average volume of 2,316,794. Blend Labs, Inc. has a 12-month low of $1.21 and a 12-month high of $5.29. The stock has a market cap of $1.33 billion, a PE ratio of -15.32 and a beta of 1.16. The company's 50 day moving average is $3.90 and its 200 day moving average is $3.29.
Institutional Trading of Blend Labs
Several institutional investors have recently modified their holdings of the stock. Dark Forest Capital Management LP purchased a new stake in Blend Labs in the second quarter valued at $31,000. Xponance Inc. acquired a new stake in shares of Blend Labs in the second quarter valued at approximately $35,000. Caxton Associates LP purchased a new position in shares of Blend Labs during the first quarter worth approximately $60,000. Virtu Financial LLC acquired a new position in shares of Blend Labs in the 3rd quarter valued at $63,000. Finally, SG Americas Securities LLC purchased a new stake in Blend Labs in the 1st quarter valued at $70,000. Hedge funds and other institutional investors own 52.56% of the company's stock.
Analysts Set New Price Targets
Several equities analysts have recently commented on BLND shares. UBS Group upped their price objective on shares of Blend Labs from $3.00 to $4.00 and gave the stock a "neutral" rating in a report on Wednesday, October 23rd. William Blair upgraded Blend Labs from a "market perform" rating to an "outperform" rating in a research report on Friday, August 9th. Canaccord Genuity Group upgraded Blend Labs from a "hold" rating to a "buy" rating and boosted their price objective for the company from $3.00 to $4.75 in a report on Monday, August 12th. Keefe, Bruyette & Woods raised their target price on Blend Labs from $3.25 to $3.85 and gave the company a "market perform" rating in a report on Thursday, November 7th. Finally, Canaccord Genuity Group upped their target price on shares of Blend Labs from $4.75 to $5.75 and gave the stock a "buy" rating in a research note on Thursday, November 7th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $4.46.
Get Our Latest Stock Analysis on BLND
About Blend Labs
(
Get Free Report)
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Blend Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.
While Blend Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.